GLAXOSMITHKLINE FDA Approval ANDA 062036

ANDA 062036

GLAXOSMITHKLINE

FDA Drug Application

Application #062036

Application Sponsors

ANDA 062036GLAXOSMITHKLINE

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTIONEQ 500,000 UNITS BASE/VIAL0AEROSPORINPOLYMYXIN B SULFATE

FDA Submissions

ORIG1AP1980-11-13

CDER Filings

GLAXOSMITHKLINE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62036
            [companyName] => GLAXOSMITHKLINE
            [docInserts] => ["",""]
            [products] => [{"drugName":"AEROSPORIN","activeIngredients":"POLYMYXIN B SULFATE","strength":"EQ 500,000 UNITS BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"AEROSPORIN","submission":"POLYMYXIN B SULFATE","actionType":"EQ 500,000 UNITS BASE\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.